Skip to content Skip to footer

World neglected tropical diseases (NTDs) day

World neglected tropical diseases (NTDs) day

Editor: Dr. Praful B. Godkar (Ph.D)
Eminent Author, Medical Biochemist and Scientist, Technical Education consultant.
AGD Biomedicals (Pvt) LTD. Andheri East, Mumbai.

Importance of early diagnosis of neglected tropical diseases came into prominence recently after significant increases in the cases of Guillain-Barre syndrome (GBS)  caused by primary infection of Campylobacter jejuni(1,4) and also by substantial increases in coinfections of  dengue and chikungunya cases with malaria in India and other Asian countries(2,3). Reliable diagnosis of neglected tropical diseases is possible by fourth generation routine IVD clinical laboratory tests (Refer to Case study 1 and 2). However, accurate diagnosis of NTDs is not achieved in many cases due to inappropriate ways of selection of tests, specimen collection and follow up procedures. Latest devised fifth generation point-of-care tests (POCT) based on rapid immunochromatographic test (ICT) principles are extremely useful for a fast diagnostic outcome(5,6,7). Persons affected by NTDs also suffer from long-term secondary diseases, which cause decreased physical fitness, work productivity and additional financial burden due to prolonged medical Treatments(1,4,8,10)(Refer to case studies 1 and 2). With increased use and easy access to POCT technologies, reduction in NTD burden could indirectly promote economic development(6).

Q1. What are neglected tropical diseases (NTDs)?

ANS: Neglected Tropical Diseases (NTDs) are endemic among underprivileged populations, due to the unavailability or inadequate clinical laboratory test facilities(8).

Q2. What are the major NTDs affecting Indian population?

ANS: The major NTDs in India: Ascariasis, Hookworm disease, Trichuriasis, Dengue, Lymphatic Fileriasis (LF), Trachoma, Cysticercosis, Leprosy, Cystic echinococcosis, Visceral leishmaniasis, and Rabies(8).

Q3. What is the prevalence of NTDs in India and in the world?

ANS: It is estimated that NTDs in the world affect more than 1 billion people, while the number of people requiring NTD interventions (both preventive and curative) is about 1.6 billion(8). According to the latest study, India experiences the world’s largest absolute burden (about 20-30%) of at least 11 major NTDs(8).

Q4. What is Guillain-Barre syndrome (GBS)?

ANS: Guillain-Barre syndrome (GBS) is a neurological disorder, a secondary clinical condition, caused by primary bacterial infection such as Campylobacter jejuni, Mycoplasma pneumonia or by a viral infection such as COVID 19, Cytomegalovirus, Epstein-Barr virus, etc. In GBS antibodies produced against the microbial infection also attack patient’s neurological system. The patient suffers from severe pain, sensation changes, difficulty in walking, swallowing, speaking, breathing, coordination, affected vision, abnormal heart rate, increase in blood clots, low blood pressure, diarrhea, etc. and in severe cases, paralysis.

Q5. What are the routine IVD laboratory tests useful to detect NTDs?

ANS: The routine IVD laboratory tests: Complete hemogram (CBC), POCT multi-strip tests and routine feces examination.

Q6. What is the importance of complete hemogram (CBC) test in the detection of NTDs?

ANS: Complete hemogram gives the following various diagnostic advantages about NTDs(11):

  1. Significant decrease in platelets may be seen in dengue, malaria, chikungunya and leptospirosis.
  2. Significant decrease in blood hemoglobin is observed in infections such as malaria, hookworm, Helicobacter pylori, etc.
  3. Microscopic examination of stained blood (collected during fever) smear can detect malarial parasites, microfilariae, leishmania and trypanosoma organisms.

Q7. What is the importance of POCT dip-sticks (multi-strip) and routine examination of feces in the detection of NTDs?

ANS: POCT dip-sticks (multi-strip) can detect occult blood in feces in one minute, which gives idea about gastro-intestinal microbial infections leading to intestinal bleeding, as well as worm infestations leading to intestinal bleeding. Microscopic examination of feces can detect Ameba, Giardia, Round worm, Hook worm, Whip worm, Strongyloides, and Platyhelminth infections.

Q8. What are the latest innovations in IVD that could significantly impact the monitoring and management of IVDs?

ANS: Latest Fifth-generation Rapid Immunographic Test (ICT) cards can detect NTDs such as malaria, dengue, chikungunya, leptospirosis, etc., in 2-3 minutes at patient bedside(1,2,3). Once diagnosis of primacy disease is known early, secondary diseases could be cured early with effective therapy.

Q9. How does timely detection of NTDs through IVD impact patient outcomes and overall healthcare costs?

ANS: The following Case studies give ideas on how these patients suffered for several months, before a correct diagnosis was made about their respective sickness. Apart from prolonged suffering with health-related issues, there was substantial financial loss and time:

CASE STUDY 1

A 46-year-old male presented with fever, chills, headache, myalgia, bleeding of gums and deep bone pain. His hemogram indicated a significant decrease in platelets. Blood smears were prepared (during fever), and Field stained observations under the microscope did not show the presence of malarial parasites on two consecutive days.

PARAMETER VALUE REFERENCE RANGE (NORMAL RANGE)
Complete Blood Count (CBC)
Hemoglobin 13.2 g 13-17 g
Total WBC count 7,800 per µl 5000-10,000 per µl
Differential WBC count
Neutrophils 64% 40-75%
Lymphocytes 32% 20-45%
Eosinophils 04% 1-4 %
Red blood cell indices
(MCV, MCH, MCHC) Normal findings
Platelet count 55,000 per µl

According to the symptoms and history of the patient, following additional tests were performed:

  • Dengue NS1 Ag assay: Positive
  • Dengue IgM: Positive
  • Dengue IgG: Negative
  • Chikungunya virus nucleic acid by RT-PCR test: Negative

Note :

  1. Patient was suffering from Dengue fever. Malarial parasites and Chikungunya virus were not detected and the infection was primary since Dengue IgM was positive and Dengue IgG was negative.
  2. Patient suffered from muscle and joint pain for long time and financial loss incurred during treatment and recovery.
  3. Appropriate preventive measures by mosquito  control could have been used effectively (using mosquito repellents, nets and fogging) and water logging (to avoid mosquito breeding) in areas near house and building.
  4. Severe dengue is a medical emergency; due to very low blood platelets, low blood pressure, hypovolemic shock and   failure of  various organs such as kidneys, liver and heart ultimately leading to death, if not treated in time.

CASE STUDY 2

A 27 year-old-woman presented with weakness, fatigue, loss of weight, abdominal pain, occasional diarrhea, palpitations, and dyspnea on exertion. Her blood histogram and other laboratory test reports were as follows

PARAMETERVALUEREFERENCE RANGE (NORMAL RANGE)
Complete Hemogram
Hemoglobin6.8 g/dl12–16 g/dl
Total erythrocyte count3.03 X 1012/l4.3 ± 0.5 X 1012/l
Total leukocyte count5.1 X 109/l7.0 ± 3.0 X 109/l
Differential leukocyte count
Neutrophils32%40-75%
Lymphocytes62%20-45%
Eosinophils3%1-4 %
Monocytes01%2–8 %
Stained peripheral blood smear
Microscopic observations:
Hypochromia+++Normal cells
Microcytosis++Normal cells
Anisocytosis+++Normal cells
   
PCV21%36–48%
MCV71.7 fL82–92 fL
MCH19.1 pg27–32 pg
MCHC26.7 %32–36 %
RDW- CV16.112–14
Platelet count177 X 109/l150–400 X 109/l

NOTE: 

  1. The complete hemogram report indicated ‘Hypochromic microcytic  Anemia’ on the basis of low values of Hb, RBC count, PCV, MCV, MCH, MCHC, and high RDW.
  2. After two months of treatment to improve blood hemoglobin, no significant improvement in blood hemoglobin was observed. Routine feces examination was prescribed. The following were main findings –

ROUTINE FECES EXAMINATION:

PARAMETERVALUEREFERENCE RANGE (NORMAL RANGE)
Occult bloodPresent, ++(occult blood is absent in a normal feces specimen)
Microscopic examinationOva of hook worm were detected 
 

NOTE: 

  1. Due to hook worm infection, continuous bleeding from small intestine, blood hemoglobin level remained low.
  2. Blood hemoglobin level of the patient improved, after specific deworming treatment.

Q10. What are the various measures suggested to control NTDs

ANS: The following various measures are suggested:

  1. Use of safe drinking water and foods
  2. Practice of good hygiene and sanitation
  3. Control of spread of vectors such as mosquitoes, flies, worms, etc.
  4. Good education of veterinary public health that includes deworming and vaccination of domestic animals, periodic check-ups and food safety
  5. Effective use of Immunizations
  6. Snake bite prevention and management
  7. Stray dog sterilization

References

(1) Cases of Guillain-Barre syndrome (GBS): Dhayari and Narhe regons of Southern part of Pune, Maharastra, India. Times of India dated 23rd January 2023.

(2) Harendra S Chahar, Preeti Bharaj, Lalit Dar, Randeep Guleria, Sushil K Kabra, Shobha BrooEmerg. Co-infections with Chikungunya Virus and Dengue Virus in Delhi, India. Infect Dis. 2009 Jul;15(7):1077–1080. doi: 10.3201/eid1507.080638.

(3) Myers RM, Carey DE. Concurrent isolation from patient of two arboviruses, chikungunya and dengue type 2. Science. 1967;157:1307–8. 10.1126/science.157.3794.1307.

(4) Francesca Schiaffino, Josh M. Colston,  Maribel Paredes Olortegui, Pablo Peñataro Yori, Evangelos Mourkas, Ben Pascoe, Aldo A.M. Lima , Carl  Mason, Tahmeed Ahmed, Gagandeep Kang, Estomih Mdumaj, Amidou Samie, Anita Zaidi, Jie Liu,  Kerry K. Cooper, Eric R. Houpt, Craig T. Parker, Gwenyth O. Lee , Margaret N. Kosek. The epidemiology and impact of persistent Campylobacter infections on childhood growth among children 0–24 months of age in resource-limited settings. eClinicalMedicine. Volume 76, October 2024, 102841.

(5) Mitasha Bharadwaj, Michel Bengtson, Mirte Golverdingen, Loulotte Waling, Cees Dekker. Diagnosing point-of-care diagnostics for neglected tropical diseases. PLoS Negl Trop Dis. 2018 Mar 22;12(3):e0006038. doi: 10.1371/journal.pntd.0006038.

(6) Luppa P, Junker R, editors. Point-of-Care Testing, Principles and Clinical Applications. Berlin Heidelberg: Springer-Verlag; 2018. ISBN: 978-3-662-54497-6.

(7) Shephard M, editor. A practical guide on global point-of-care testing. CSIRO Publishing; 2016. ISBN: 9781486305186.

(8) Peter J Hotez, Ashish Damania, Herricks JR, Hotez PJ, Wanga V, Coffeng LE, Haagsma JA, et al. 2017. The Global Burden of Disease Study 2013: What does it mean for the NTDs? PLoS Negl Trop Dis 11(8): e0005424 doi: 10.1371/journal.pntd.0005424 [DOI] [PMC free article] [PubMed].

(9) World Health Organization. Neglected Tropical Diseases. http://www.who.int/neglected_diseases/diseases/en/. Accessed August 3, 2017.

(10) Hotez PJ, Pecoul B, Rijal S, Boehme C, Aksoy S, Malecela M, et al. (2016) Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies. PLoS Negl Trop Dis 10(3): e0003895 doi: 10.1371/journal.pntd.0003895 [DOI] [PMC free article] [PubMed].

(11) Godkar PB, Godkar DP. Text book of Medical laboratory technology (4th edition, 2024), Bhlani Publishers, Mumbai. India.

Share The Article :